相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Insulators recruit histone methyltransferase dMes4 to regulate chromatin of flanking genes
Priscillia Lhoumaud et al.
EMBO JOURNAL (2014)
Point mutation E1099K in MMSET/NSD2 enhances its methyltranferase activity and leads to altered global chromatin methylation in lymphoid malignancies
J. A. Oyer et al.
LEUKEMIA (2014)
Overexpression of multiple myeloma SET domain (MMSET) is associated with advanced tumor aggressiveness and poor prognosis in serous ovarian carcinoma
Shanshan Yang et al.
BIOMARKERS (2013)
EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation
Wendy Beguelin et al.
CANCER CELL (2013)
The Methyltransferase NSD3 Has Chromatin-binding Motifs, PHD5-C5HCH, That Are Distinct from Other NSD (Nuclear Receptor SET Domain) Family Members in Their Histone H3 Recognition
Chao He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Characterization of the EZH2-MMSET Histone Methyltransferase Regulatory Axis in Cancer
Irfan A. Asangani et al.
MOLECULAR CELL (2013)
MMSET stimulates myeloma cell growth through microRNA-mediated modulation of c-MYC
D-J Min et al.
LEUKEMIA (2013)
Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia
Jacob D. Jaffe et al.
NATURE GENETICS (2013)
EZH2 promotes a bi-lineage identity in basal-like breast cancer cells
R. Z. Granit et al.
ONCOGENE (2013)
The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer
T. Ezponda et al.
ONCOGENE (2013)
Overexpression of MMSET is Correlation with Poor Prognosis in Hepatocellular Carcinoma
Peng Zhou et al.
PATHOLOGY & ONCOLOGY RESEARCH (2013)
Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasms
Joannah Score et al.
BLOOD (2012)
ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression
Omar Abdel-Wahab et al.
CANCER CELL (2012)
Drosophila CTCF tandemly aligns with other insulator proteins at the borders of H3K27me3 domains
Kevin Van Bortle et al.
GENOME RESEARCH (2012)
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Jeremy Schwartzentruber et al.
NATURE (2012)
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
Michael T. McCabe et al.
NATURE (2012)
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
Jinghui Zhang et al.
NATURE (2012)
An integrated encyclopedia of DNA elements in the human genome
Ian Dunham et al.
NATURE (2012)
Understanding the language of Lys36 methylation at histone H3
Eric J. Wagner et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Total kinetic analysis reveals how combinatorial methylation patterns are established on lysines 27 and 36 of histone H3
Yupeng Zheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2
Sharad K. Verma et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
Emerging Epigenetic Targets and Therapies in Cancer Medicine
Relja Popovic et al.
CANCER DISCOVERY (2012)
Antagonism between MES-4 and Polycomb Repressive Complex 2 Promotes Appropriate Gene Expression in C. elegans Germ Cells
Laura J. Gaydos et al.
CELL REPORTS (2012)
The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells
Eva Martinez-Garcia et al.
BLOOD (2011)
NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern
Iris H. I. M. Hollink et al.
BLOOD (2011)
An integrated ChIP-seq analysis platform with customizable workflows
Eugenia G. Giannopoulou et al.
BMC BIOINFORMATICS (2011)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
The Histone Methyltransferase and Putative Oncoprotein MMSET Is Overexpressed in a Large Variety of Human Tumors
Heidi Rye Hudlebusch et al.
CLINICAL CANCER RESEARCH (2011)
H3K36 Methylation Antagonizes PRC2-mediated H3K27 Methylation
Wen Yuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
NSD2 Links Dimethylation of Histone H3 at Lysine 36 to Oncogenic Programming
Alex J. Kuo et al.
MOLECULAR CELL (2011)
Histone Methylation by PRC2 Is Inhibited by Active Chromatin Marks
Frank W. Schmitges et al.
MOLECULAR CELL (2011)
Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma
W-J Chng et al.
LEUKEMIA (2011)
Structural and Histone Binding Ability Characterizations of Human PWWP Domains
Hong Wu et al.
PLOS ONE (2011)
CpG Islands Recruit a Histone H3 Lysine 36 Demethylase
Neil P. Blackledge et al.
MOLECULAR CELL (2010)
Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities
Sven Heinz et al.
MOLECULAR CELL (2010)
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
Gillian L. Dalgliesh et al.
NATURE (2010)
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
Ryan D. Morin et al.
NATURE GENETICS (2010)
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
Thomas Ernst et al.
NATURE GENETICS (2010)
Polycomb Target Genes Are Silenced in Multiple Myeloma
Antonia Kalushkova et al.
PLOS ONE (2010)
Polycomb group protein-mediated repression of transcription
Lluis Morey et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
GC-Rich Sequence Elements Recruit PRC2 in Mammalian ES Cells
Eric M. Mendenhall et al.
PLOS GENETICS (2010)
Jarid2/Jumonji Coordinates Control of PRC2 Enzymatic Activity and Target Gene Occupancy in Pluripotent Cells
Jamy C. Peng et al.
CELL (2009)
The Target of the NSD Family of Histone Lysine Methyltransferases Depends on the Nature of the Substrate
Yan Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Revealing Global Regulatory Perturbations across Human Cancers
Hani Goodarzi et al.
MOLECULAR CELL (2009)
A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome
Keisuke Nimura et al.
NATURE (2009)
Role of the polycomb protein EED in the propagation of repressive histone marks
Raphael Margueron et al.
NATURE (2009)
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer
Gijs van Haaften et al.
NATURE GENETICS (2009)
Mutation in TET2 in Myeloid Cancers
Francois Delhommeau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome
Elaine R. Mardis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The multiple myeloma-associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity
Josh Lauring et al.
BLOOD (2008)
PHD fingers in human diseases: Disorders arising from misinterpreting epigenetic marks
Lindsey A. Baker et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2008)
Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation
Yutaka Kondo et al.
NATURE GENETICS (2008)
Model-based Analysis of ChIP-Seq (MACS)
Yong Zhang et al.
GENOME BIOLOGY (2008)
A universal framework for regulatory element discovery across all Genomes and data types
Olivier Elemento et al.
MOLECULAR CELL (2007)
NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis
Gang G. Wang et al.
NATURE CELL BIOLOGY (2007)
High-resolution profiling of histone methylations in the human genome
Artern Barski et al.
CELL (2007)
Role of the polycomb repressive complex 2 in acute promyelocytic leukemia
Raffaella Villa et al.
CANCER CELL (2007)
Ten years and counting: so what do we know about t(4;14)(p16;q32) multiple myeloma
Jonathan J. Keats et al.
LEUKEMIA & LYMPHOMA (2006)
Polycomb complexes repress developmental regulators in murine embryonic stem cells
LA Boyer et al.
NATURE (2006)
Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions
AP Bracken et al.
GENES & DEVELOPMENT (2006)
A library of gene expression signatures to illuminate normal and pathological lymphoid biology
AL Shaffer et al.
IMMUNOLOGICAL REVIEWS (2006)
The polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion
LM Kamminga et al.
BLOOD (2006)
The Polycomb group protein EZH2 directly controls DNA methylation
E Viré et al.
NATURE (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The polycomb group protein enhancer of zeste homolog 2 (EZH2) is an oncogene that influences myeloma cell growth and the mutant ras phenotype
PA Croonquist et al.
ONCOGENE (2005)
NSD1 mutations in Sotos syndrome
F Faravelli
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2005)
The etiology of Wolf-Hirschhorn syndrome
AD Bergemann et al.
TRENDS IN GENETICS (2005)
A subset of multiple myeloma harboring the t(4;14)(p16;q32) translocation lacks FGFR3 expression but maintains an IGH/MMSET fusion transcript
M Santra et al.
BLOOD (2003)
In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression
JJ Keats et al.
BLOOD (2003)
Haploinsufficiency of NSD1 causes Sotos syndrome
N Kurotaki et al.
NATURE GENETICS (2002)
Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma
YP Shou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
